Added to Saved items
This page has been archived. It has not been updated since 28/05/2014. External links and references may no longer work.
This article is for Medical Professionals

Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find one of our health articles more useful.

Read COVID-19 guidance from NICE

Treatment of almost all medical conditions has been affected by the COVID-19 pandemic. NICE has issued rapid update guidelines in relation to many of these. This guidance is changing frequently. Please visit to see if there is temporary guidance issued by NICE in relation to the management of this condition, which may vary from the information given below.

There are various kidney diseases, ranging from relatively common to rare disorders and from benign disorders to those with a high morbidity and mortality. Presentation may also vary - eg, renal mass, loin pain, failure to thrive, short stature, hypertension or renal dysfunction.

Advances in genetic techniques are providing novel insights into kidney diseases, especially diagnosis, classification, pathogenesis and therapy. Many congenital kidney diseases are due to single gene defects (eg, some cases of nephrotic syndrome resistant to steroids). It is also becoming clear that some adult-onset kidney diseases - which are far more common - are associated with risk alleles (genetic variants linked to an increased risk of developing certain diseases). An example is focal segmental glomerulosclerosis and chronic kidney disease in African-American patients.[1]

Congenital anomalies of the kidney and urinary tract anatomy represent approximately 30% of all prenatally diagnosed malformations.[2]

  • The management will depend on the underlying disorder, degree of renal dysfunction and associated defects.
  • Genetic counselling is useful in patients and relatives where there is a defined autosomal dominant condition. However, where there is familial aggregation of congenital renal malformations with no defined genetic abnormality, genetic counselling may be of less benefit.[4]
  • The role of prenatal interventions and postnatal therapies in cases of congenital kidney and urinary tract anomalies requires further research.[2]

Are you protected against flu?

See if you are eligible for a free NHS flu jab today.

Check now

Further reading and references

  • Gigante M, Caridi G, Montemurno E, et al; TRPC6 mutations in children with steroid-resistant nephrotic syndrome and atypical phenotype. Clin J Am Soc Nephrol. 2011 Jul6(7):1626-34. doi: 10.2215/CJN.07830910.

  1. Hildebrandt F; Genetic kidney diseases. Lancet. 2010 Apr 10375(9722):1287-95. doi: 10.1016/S0140-6736(10)60236-X.

  2. Toka HR, Toka O, Hariri A, et al; Congenital anomalies of kidney and urinary tract. Semin Nephrol. 2010 Jul30(4):374-86. doi: 10.1016/j.semnephrol.2010.06.004.

  3. Zhang D, Lu L, Yang HB, et al; Exome sequencing identifies compound heterozygous PKHD1 mutations as a cause of autosomal recessive polycystic kidney disease. Chin Med J (Engl). 2012 Jul125(14):2482-6.

  4. Weber S; Novel genetic aspects of congenital anomalies of kidney and urinary tract. Curr Opin Pediatr. 2012 Apr24(2):212-8. doi: 10.1097/MOP.0b013e32834fdbd4.